DK227487A - Substituerede heterocycliske forbindelser - Google Patents

Substituerede heterocycliske forbindelser

Info

Publication number: DK227487A
Authority: DK; Denmark
Prior art keywords: substituted heterocyclic; heterocyclic compounds; compounds; substituted; heterocyclic
Prior art date: 1986-05-03

Application number

DK227487A

Other languages

English (en)

Other versions

DK227487D0 (da

Inventor

John Berge

Lee James Beeley

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-03

Filing date

1987-05-04

Publication date

1987-11-04

1987-05-04 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1987-05-04 Publication of DK227487D0 publication Critical patent/DK227487D0/da

1987-11-04 Publication of DK227487A publication Critical patent/DK227487A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DK227487A 1986-05-03 1987-05-04 Substituerede heterocycliske forbindelser DK227487A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868610909A GB8610909D0 (en)	1986-05-03	1986-05-03	Compounds

Publications (2)

Publication Number	Publication Date
DK227487D0 DK227487D0 (da)	1987-05-04
DK227487A true DK227487A (da)	1987-11-04

Family

ID=10597340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK227487A DK227487A (da)	1986-05-03	1987-05-04	Substituerede heterocycliske forbindelser

Country Status (12)

Country	Link
US (1)	US4861789A (da)
EP (1)	EP0251453B1 (da)
JP (1)	JPS62267270A (da)
AU (1)	AU600939B2 (da)
DE (1)	DE3767789D1 (da)
DK (1)	DK227487A (da)
ES (1)	ES2031890T3 (da)
GB (1)	GB8610909D0 (da)
GR (1)	GR3001416T3 (da)
NZ (1)	NZ220179A (da)
PT (1)	PT84818B (da)
ZA (1)	ZA873169B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5034406A (en) *	1989-09-26	1991-07-23	Allergan, Inc.	Method for reducing or maintaining intraocular pressure
US5066664A (en) *	1990-02-28	1991-11-19	Allergan, Inc.	2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
DK148292D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Forbindelser
US5580892A (en) *	1993-10-22	1996-12-03	Allergan	Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents
US6150389A (en)	1994-07-11	2000-11-21	Allergan Sales, Inc.	Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents
JPH10502643A (ja) *	1994-07-11	1998-03-10	アラーガン	α▲下２▼アドレナリン遮断剤として有用な、立体配座の定まった二環およびアダマンタン誘導体
DE19514579A1 (de) *	1995-04-20	1996-10-24	Boehringer Ingelheim Kg	Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
US5677321A (en) *	1996-02-29	1997-10-14	Synaptic Pharmaceutical Corporation	5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
JP2009529492A (ja) *	2006-02-15	2009-08-20	バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト	殺虫性置換アミノヘテロ環及びヘテロアリール誘導体
EP1988080A1 (en) *	2007-05-03	2008-11-05	Bayer CropScience AG	Insecticidal substituted 2-aminoindanes
KR20100017918A (ko) *	2007-05-25	2010-02-16	바스프 에스이	동물 해충의 퇴치를 위한 아미노아졸린 및 우레아 유도체
WO2009023758A1 (en) *	2007-08-15	2009-02-19	Allergan, Inc.	Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
CN101855213B (zh) *	2007-08-15	2014-09-10	阿勒根公司	治疗性化合物
ES2396269T3 (es) *	2007-08-15	2013-02-20	Allergan, Inc.	Compuestos adrenérgicos
ES2442298T3 (es) *	2008-01-18	2014-02-11	Allergan, Inc.	Agentes alfa 2 adrenérgicos selectivos de subtipo y métodos para usarlos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2883410A (en) *	1957-07-08	1959-04-21	Pfizer & Co C	N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas
US2870159A (en) *	1957-07-08	1959-01-20	Pfizer & Co C	Hydrogenated 2-(1-naphthylamino)-oxazolines
US2870161A (en) *	1957-07-08	1959-01-20	Pfizer & Co C	2-(1-indanyl amino)-oxazolines
DE1195323B (de) *	1963-06-24	1965-06-24	Thomae Gmbh Dr K	Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen
US3432600A (en) *	1963-09-30	1969-03-11	Du Pont	Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline
US3679798A (en) *	1964-02-28	1972-07-25	Du Pont	Composition comprising arylaminooxazoline and antichloligeneric agent
DE1670751A1 (de) *	1966-09-27	1970-12-23	Bayer Ag	Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) *	1966-09-27	1970-07-16	Bayer Ag	Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
US3882229A (en) *	1972-07-21	1975-05-06	Nordmark Werke Gmbh	Composition and method for shrinking mucous membranes
JPS54151990A (en) *	1978-04-17	1979-11-29	Beiersdorf Ag	Novel condensated nitrogenncontained heterocyclic compound and its manufacture

1986
- 1986-05-03 GB GB868610909A patent/GB8610909D0/en active Pending
1987
- 1987-05-04 US US07/047,720 patent/US4861789A/en not_active Expired - Fee Related
- 1987-05-04 DK DK227487A patent/DK227487A/da not_active Application Discontinuation
- 1987-05-04 ZA ZA873169A patent/ZA873169B/xx unknown
- 1987-05-04 NZ NZ220179A patent/NZ220179A/xx unknown
- 1987-05-04 AU AU72479/87A patent/AU600939B2/en not_active Ceased
- 1987-05-04 PT PT84818A patent/PT84818B/pt not_active IP Right Cessation
- 1987-05-05 DE DE8787304019T patent/DE3767789D1/de not_active Expired - Fee Related
- 1987-05-05 ES ES198787304019T patent/ES2031890T3/es not_active Expired - Lifetime
- 1987-05-05 EP EP87304019A patent/EP0251453B1/en not_active Expired - Lifetime
- 1987-05-06 JP JP62110422A patent/JPS62267270A/ja active Pending
1991
- 1991-01-31 GR GR91400101T patent/GR3001416T3/el unknown

Also Published As

Publication number	Publication date
NZ220179A (en)	1989-10-27
GB8610909D0 (en)	1986-06-11
DE3767789D1 (de)	1991-03-07
EP0251453B1 (en)	1991-01-30
EP0251453A2 (en)	1988-01-07
AU600939B2 (en)	1990-08-30
AU7247987A (en)	1987-11-05
GR3001416T3 (en)	1992-09-25
US4861789A (en)	1989-08-29
PT84818B (pt)	1989-12-29
PT84818A (en)	1987-06-01
ZA873169B (en)	1988-04-27
DK227487D0 (da)	1987-05-04
ES2031890T3 (es)	1993-01-01
JPS62267270A (ja)	1987-11-19
EP0251453A3 (en)	1988-09-28

Publication	Publication Date	Title
DK93887A (da)	1987-08-26	Heterocycliske forbindelser
DK321688D0 (da)	1988-06-13	Heterocykliske forbindelser
DK106786A (da)	1986-09-21	Heterocycliske forbindelser
FI893902L (fi)	1990-02-19	Heterosyklisiä yhdisteitä
DK517989D0 (da)	1989-10-18	Heterocykliske forbindelser
DK552685A (da)	1986-06-22	Heterocycliske forbindelser
DK162485A (da)	1985-10-12	Heterocykliske forbindelser
DK287688D0 (da)	1988-05-25	Heterocycliske forbindelser
DK496086A (da)	1987-04-18	Heterocykliske forbindelser
DK219986A (da)	1986-12-01	Nitrogenholdige heterocycliske forbindelser
NO168305C (no)	1992-02-05	Heterocykliske forbindelser
DK227487A (da)	1987-11-04	Substituerede heterocycliske forbindelser
DK64788A (da)	1988-08-11	Heterocycliske forbindelser
DK499987D0 (da)	1987-09-23	Heterocycliske forbindelser
FI892038A7 (fi)	1989-10-30	Heterosyklisiä yhdisteitä
DK496885D0 (da)	1985-10-29	Heterocycliske forbindelser
DK507289D0 (da)	1989-10-12	Heterocykliske forbindelser
DK429588A (da)	1989-02-04	Heterocykliske forbindelser
DK109586A (da)	1986-10-05	Heterocycliske forbindelser
DK397686D0 (da)	1986-08-20	Heterocycliske forbindelser
DK45887A (da)	1987-07-29	Heterocykliske forbindelser
DK343587D0 (da)	1987-07-03	Acylerede heterocycliske forbindelser
DK414886A (da)	1987-03-01	Substituerede heterocycliske forbindelser
FI872675A7 (fi)	1987-12-18	Heterocykliska foereningar.
DK565289A (da)	1990-05-12	Heterocykliske forbindelser

Legal Events

Date	Code	Title	Description
1992-01-20	AHB	Application shelved due to non-payment